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Staphylococcus aureus sarA Attenuation
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A novel membrane-associated protein, MsrR, was identified in Staphylococcus aureus which affects resistance
to methicillin and teicoplanin, as well as the synthesis of virulence factors. MsrR belongs to the LytR-CpsA-Psr
family of cell envelope-related transcriptional attenuators and was shown to be inducible by cell wall-active
agents, such as -lactams, glycopeptides, and lysostaphin. The expression of msrR peaked in the early expo-
nential growth phase and decreased sharply thereafter.msrRmutants showed increased sarA transcription and
an earlier and higher expression of RNAIII, resulting in altered expression of virulence factors such as alpha-
toxin and protein A. These observations suggest that MsrR is a new component involved in sarA attenuation
and the regulatory network controlling virulence gene expression in S. aureus.
Staphylococcus aureus, an inhabitant of the skin and mucous
membranes in 10 to 30% of the healthy population, easily
survives in the environment and is, moreover, the most com-
mon cause of community-acquired and nosocomial infections.
The pathogenicity of S. aureus is based on an impressive rep-
ertoire of virulence factors. The diseases caused range from
superficial infections of the skin to life-threatening infections
such as septicemia, endocarditis, osteomyelitis, and toxic shock
syndrome. Virulence factors comprise surface-associated and
extracellular proteins such as toxins and enzymes. Cell surface-
associated proteins, the MSCRAMMs (microbial surface com-
ponents recognizing adhesive matrix molecules), function in
adhesion and colonization of the host and evasion of host
defenses. Cell surface-associated factors are needed primarily
during the initial stages of infection and are expressed mainly
in the early exponential growth phase. The exoenzymes, which
damage the host tissue and promote dissemination of the
pathogen and most soluble exoproteins, have a role in a later
stage of the infection and are produced in the postexponential
phase. The coordinate and timely expression of those virulence
factors during the growth cycle is governed by a complex net-
work comprising two-component sensor transducers, global
regulatory systems, and transcription factors, which are impor-
tant for the pathogen to adapt to the changing host environ-
ment during different stages of infection (2, 21, 23, 26). One of
the two major global regulatory systems is the agr (accessory
gene regulator) regulon. This locus consists of two divergent
transcripts originating from the promoters P2 and P3, which
produce RNAII and RNAIII, respectively. The RNAII tran-
script encodes four proteins, AgrA to AgrD. AgrA and AgrC
form a two-component regulatory system whereby AgrC acts
as the signal receptor and AgrA acts as sensor regulator. The
signal is a small peptide processed from AgrD by AgrB. This
self-encoded autoinducing peptide determines the specificity
group of S. aureus (29). The autoinducer leads from the phos-
phorylation of AgrC to the phosphorylation of AgrA, which
upregulates both P2 and P3 promoters of the agr regulon. The
RNAIII molecule is the effector molecule, which controls the
expression of cell wall-associated and virulence proteins in a
growth-dependent manner (36). The second major regulatory
system is the sarA (staphylococcal accessory regulator A) locus
(14, 18). SarA is a transcriptional regulator that binds to a
consensus motif in the promoter of its target genes and has
positive and negative regulatory effects on extracellular protein
synthesis (48). SarA interacts with the agr system by binding to
the agr promoter region, to stimulate the transcription of
RNAII and RNAIII from the P2 and P3 promoters, respec-
tively (4). SarA forms part of a family of SarA-related proteins,
which participate in the SarA-RNAIII regulatory cascade and
have regulatory functions as well (16).
Global regulators and effector molecules are important in
the life cycle of S. aureus. They not only govern virulence
factors but also are involved in the modulation of antibiotic
resistance levels. Compromised agr function was found to help
clinical isolates of S. aureus develop vancomycin heteroresis-
tance (39). The sarA and agr operons were found to affect
methicillin resistance (37), and high activity of transcription
factor B was shown to correlate with increased teicoplanin
resistance (9) and high-level methicillin resistance (46). In this
work we describe a novel potential sensor of cell wall damage,
which influences sarA and agr transcription.
MATERIALS AND METHODS
Strains and culture conditions. The strains and plasmids used are listed in
Table 1. Strains were grown in Luria-Bertani broth (Becton Dickinson, Sparks,
Md.) at 37°C unless specified otherwise. Transductions were performed with
phage 85 (5). Erythromycin at 10 g ml1, tetracycline at 10 g ml1, or
kanamycin at 20 g ml1 was added to the medium when needed. MICs of
antibiotics were determined by Etest (AB-Biodisk, Solna, Sweden) on Mueller-
Hinton agar plates with an inoculum of an 0.5 McFarland standard after 24 h of
incubation at 35°C or by broth microdilution as recommended by the NCCLS
(35). MICs of teicoplanin and vancomycin were determined on brain heart
infusion agar after 48 h of incubation at 35°C. Antibiotic resistance levels were
compared by swabbing an 0.5 McFarland standard suspension of overnight cul-
tures along an antibiotic gradient in rectangular agar plates.
* Corresponding author. Mailing address: Institute of Medical Mi-
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Molecular biological methods. Standard molecular biology procedures were
performed essentially according to the protocols of Sambrook et al. (40) and
Ausubel et al. (3). Total RNA was isolated as described by Cheung et al. (12),
with a FastRNA kit and a Fastprep reciprocating shaker (Bio 101, Vista, Calif.).
Digoxigenin-labeled DNA was produced using the PCR DIG Probe synthesis kit
(Roche, Rotkreuz, Switzerland). Primers used are listed in Table 2. Probes for
sarA and RNAIII were those described earlier (9, 22). For Northern blots, 6 g
of total RNA was loaded per lane. Chromosomal sequencing was performed
according to the protocol of A. Wada (45) on an ABI Prism 310 genetic analyzer
(Applied Biosystems, Foster City, Calif.). For sequencing the msr region a 1.8-kb
fragment was amplified using primers JR1 and JR2. Homology searches were
performed with the program Blast (http://www.ncbi.nm.nih.gov/BLAST) (1). Se-
quence data were analyzed with the GCG sequence analysis software package,
version 9 (Genetics Computer Group, University of Wisconsin, Madison).
Primer extension was performed using 40 g of total RNA from early exponen-
tial growth and 3 pmol of the -32P-labeled primer JR7 or JR8 for msrR or JR11
and JR12 for msrA, respectively, with Omniscript reverse transcriptase (Qiagen,
Hilden, Germany), according to the instructions of the manufacturer. The se-
quencing reaction was performed with the Thermo Sequenase cycle sequencing
kit (U.S. Biochemicals, Cleveland, Ohio).
Construction of mutants and plasmids. For allelic replacement of msrR, a 1-kb
fragment covering the 5 region of msrR was amplified from strain BB270 with
primers JR3 and JR4 and cloned 5 to the ermB resistance cassette of vector
pEC1 (11). A 1-kb fragment covering the 3 region of msrR amplified with
primers JR5 and JR6 was subsequently cloned downstream of the ermB cassette.
The insert was then subcloned into the suicide vector pBT (22), resulting in
plasmid pJR3, which was electroporated into RN4220. Mutants with the
msrR::ermB allelic replacement were selected for Ermr and screened for loss of
Tetr. The msrR::ermB construct was then transduced into different genetic back-
grounds. The plasmid pAW17(msrAR) used for complementation was con-
structed by cloning a 1.7-kb DNA fragment generated with primers JR9 and
JR10, covering msrAR, into pAW17. Luciferase reporter gene fusions were
constructed by amplifying the desired promoter regions and cloning them 5 to
the firefly luciferase gene luc of the pSP-luc vector (Promega, Madison,
Wis.). For msrRp- luc, a DNA fragment covering 709 bp of the msrR promoter
region of strain MSSA1112 was generated by PCR with upstream primer JR13,
including a KpnI linker, and downstream primer JR14, including an NcoI site.
For mecAp- luc, a DNA fragment covering 895 bp of the mecA promoter region
of the SCCmec element of S. aureus BB270 was generated by PCR with upstream
primer JR15, including a KpnI site, and downstream primer JR16, including an
NcoI site. The PCR products obtained were digested with KpnI and NcoI and
TABLE 2. Primers
Primer Sequencea (5-3)
JR1 GGGATCCTGAGCTAAAGTTAAGTCGCC
JR2 TGAATTCAAACCATTATGGTGTGGCTGG
JR3 CGGATCCTGGCATATTCTACACCGC
JR4 GGAATTCAGTTATGCCTGATGCGCTTGG
JR5 CATTGACTGCAGCAATCAAGAACTCATACGAAG
JR6 GACTAAGCTTCGCTTCAACATCCATAGC
JR7 CGTTGTCATTAGTTTCTTTATC
JR8 TCAGAAGAATGATAGGTAATTTC
JR9 ATTTCAGATCTGTACCGTATTTTAATATTG
JR10 ATTTCAGATCTGAGTATGATAGAAATCG
JR11 GCAAAATAAGCTGTATTAATATTC
JR12 CAAATGGTTTCGTCATACAC
JR13 GGGTACCTGAGCTAAAGTTAAGTCGCC
JR14 TATCCATGGTTACCTACCTTATATCTTC
msrR AATGGACCAGTAAAAAATGATG
msrR for rev CCTCGGATACCAAAACTCAAAC
msrA GGGATCCTGAGCTAAAGTTAAGTCGCC
msrA for rev GAGGTACCTTTTGGTGTATGACGAAACC
sarR CTTCTAATTCTGAAATCAG
sarR for rev GACATTAATGATTTAGTCAAC
hla GTGATGGAAAATAGTTGATGAG
hla for rev GTGAATTTGTTCACTGTGTCG
spa TGAATTCGTAAACTAGGTGTAGG
spa for rev CGGTACCAGGCTTGTTATTGTCTTCC
a Restriction enzyme sites used in this work are underlined.
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant genotype and phenotypea Reference or source
Escherichia coli
DH5 F 80d/acZ	M15 recA1 Invitrogen
Staphylococcus aureus
RN4220 NCTC8325-4 r m; recipient for electroporations 25
J126 RN4220 msrR::ermB This study
BB270 Essentially the same as NCTC8325; rsbU mec 6
BB1259 BB270 
2020chr::Tn551 44
J141 BB270 msrR::ermB This study
J190 J141[pAW17(msrAR)] This study
J191 J141(pAW17) This study
BB938 Essentially the same as 8325; Tcr 10
J161 BB938 msrR::ermB This study
MSSA1112 Clinical isolate; bla 20
J156 MSSA1112 msrR::ermB This study
J175 MSSA1112 msrR::pEC1(msrRp-luc) msrR
 This study
J198 MSSA112[pBUS(mecAp-luc)] This study
J192 J156[pBUS(mecAp-luc)] This study
J209 J156(pAW17) This study
J210 J156[pAW17(msrAR)] This study
Plasmids
pAW17 S. aureus-E. coli shuttle vector ori pAM1-ori ColE1 aac-aph; Gmr Kmr This study
pAW17 (msrAR) 1.5-kb fragment covering msrAR cloned in pAW17 This study
pBUS1 S. aureus-E. coli shuttle vector pAW8 (42) with multicloning site from pBluescript II SK
(Stratgene) and the rrnT14 terminator sequence from pLL2443 (24)
S. Burger, unpublished data
pJR3 pBT with a 3.45-kb insert containing the ermB cassette from pEC1 substituting for msrR,
flanked on both sides by 1-kb chromosomal sequences from BB270; Tetr
This study
pEC1(msrRp-luc) 2.3-kb KpnI-EcoRI msrRp-luc fragment cloned in pEC1; Ap
r Ermr This study
pBUS1(mecAp-luc) 2.5-kb KpnI-EcoRI mecAp-luc fragment cloned in pBUS1; Tet
r This study
a Abbreviations: Apr, ampicillin resistant; Ermr, erythromycin resistant; Gmr, gentamicin resistant; Kmr, kanamycin resistant; Mcr, methicillin resistant; Tcr,
teicoplanin resistant; Tetr, tetracycline resistant.
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cloned in frame with the 5 end of the luciferase gene of plasmid pSP-luc.
Sequence analysis confirmed the identity of the constructs. The 2.3-kb KpnI-
EcoRI fragment, including the msrR promoter region fused to the luciferase
coding region, was subsequently cloned into suicide plasmid pEC1 to obtain
plasmid pEC1(msrRp- luc), which was electroporated into RN4220 and trans-
duced into MSSA1112, resulting in strain J175. Plasmid pBUS1(mecAp- luc)
was generated by cloning the 2.5-kb KpnI-EcoRI fragment, including the mecA
promoter region fused to the luciferase coding region, into the Escherichia coli-
S. aureus shuttle vector pBUS1. All constructs were verified by restriction anal-
ysis, Southern blotting, and pulsed-field gel electrophoresis.
Enzymatic assays. Luciferase activity was determined as described earlier (9)
using the luciferase assay substrate and a Turner Designs TD-20/20 luminometer
(Promega). Spontaneous autolysis was measured in cells that were grown at
37°C, harvested at mid-exponential phase, washed twice with cold phosphate-
buffered saline, and resuspended in 0.05 M Tris-HCl (pH 7.5), by determining
turbidity loss as optical density at 600 nm (OD600) when incubated with shaking
(200 rpm) at 37°C. Penicillin-binding proteins (PBPs) from membrane prepara-
tions of exponentially growing cells were labeled with [3H]penicillin and sepa-
rated on sodium dodecyl sulfate-polyacrylamide gels as described earlier (8).
Nucleotide sequence accession number. The nucleotide sequence was depos-
ited in the EMBL and GenBank nucleotide sequence databases under accession
number AF311784.
RESULTS
Insertion site characterization. The insertion 
2020::Tn551
was reported to increase susceptibility to -lactams in S. au-
reus, but its nature remained unsolved (44). Sequencing of the
insertion site revealed that the transposon had integrated into
the intercistronic region of two divergently transcribed genes,
tentatively termed msrA and msrR, which are separated by 136
nucleotides (Fig. 1). The msrA gene was shown to code for a
peptide methionine sulfoxide reductase, MsrA2, specific for
the S isomer of methionine sulfoxide (34). The msrR gene has
not yet been characterized; the deduced amino acid sequence
includes a hypothetical protein of 327 amino acids with
44% identity and 66% similarity to Enterococcus faecalis Psr
(U42211) and 42% identity and 66% similarity to Bacillus
subtilis LytR, which belong to the LytR-CpsA-Psr family of
cell envelope-related transcriptional attenuators. A predicted
transmembrane domain in the N-terminal part of MsrR divides
MsrR into a shorter, presumably intracellular domain and a
larger, extracellular domain. Analysis of the MsrR amino acid
sequences obtained by the public genome sequencing projects
revealed that the protein is strictly conserved among S. aureus
strains.
The open reading frames of msrA and msrR are each termi-
nated by a structure resembling a putative rho-independent
terminator, suggesting that they lie on monocistronic tran-
scripts. Interestingly, primer extension showed that msrA and
msrR share the same nucleotide for the transcriptional start
(Fig. 1). The Tn551 insertion mapped 2 nucleotides upstream
of the msrA transcriptional start. Northern blots showed that

2020::Tn551 abolished the transcription of both msrA and
msrR (data not shown).
Phenotype of msrR inactivation. To determine if only one of
the two inactivated genes was responsible for the increased
-lactam susceptibility, we replaced msrR with an ermB resis-
tance cassette in strain RN4220 and transduced the inactivated
msrR::ermB gene into the methicillin-resistant strain BB270.
The resulting strain, J141, showed a fourfold-lower resistance
to oxacillin than did the parent (Fig. 2), suggesting that msrR
inactivation was responsible for the reduced resistance. Oxacil-
lin resistance could be restored by complementing strain J141
with plasmid pAW17(msrAR), supporting the MsrR effect on
oxacillin resistance levels (Fig. 2). Transduction of msrR::ermB
into the teicoplanin-intermediate-resistant strain BB938 re-
duced the teicoplanin MIC for the strain twofold, from 16 to
8 g ml1, showing that MsrR had an effect on teicoplanin
resistance as well.
Expression of msrR during growth. The transcription profile
of msrR during growth in liquid culture was determined by two
different methods. Both the Northern blots with the wild-type
strain MSSA1112 and the msrRp-luciferase reporter activity in
FIG. 1. Genetic organization of the msrAR region. (A) Transcriptional start points (*) for msrR and msrA were determined by primer extension
as outlined in Materials and Methods. (B) msrA-msrR intercistronic region. Transposon Tn551 integration site (inverted triangle), transcriptional
starts of msrA and msrR (1), ribosomal binding sites (RBS), and 10 and 35 boxes are indicated.
FIG. 2. Effects of msrR inactivation and complementation of oxa-
cillin resistance. The methicillin-resistant strain BB270, its msrR mu-
tant J141, strain J190 [J141 complemented by pAW17(msrAR)], and
control strain J191 [J141(pAW17)] were swabbed along a plate con-
taining an oxacillin gradient. The corresponding MICs of oxacillin (in
micrograms per milliliter) for the strains are indicated.
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the isogenic strain J175 showed that msrR transcription peaked
in the early exponential growth phase and decreased towards
the late exponential and stationary phases (Fig. 3). The tran-
scription profile of msrA was the reverse, lower in the expo-
nential phase and increasing towards the stationary phase.
Interestingly, in the msrR mutant J156, msrA transcription was
strongly enhanced over the entire growth cycle compared to
that in the wild type (Fig. 3B). The sizes of the msrA and msrR
mRNAs, 0.5 and 1 kb, respectively, indicated that both genes
are located on monocistronic transcripts, as predicted from the
nucleotide sequence.
Induction of msrR by antibiotic stress. Knowing that msrR
inactivation resulted in lower oxacillin resistance, we analyzed
the response of msrR to different cell wall-active antibiotics by
measuring the msrRp-luciferase reporter activity in strain J175.
The antibiotics were added at concentrations corresponding to
their MICs to exponentially growing cultures. Since staphylo-
cocci are known to show a strong inoculum effect with glyco-
peptides, vancomycin and teicoplanin were added at 5 their
MICs. Transcription of msrR was found to be induced approx-
imately two- to fivefold by (i) -lactam derivatives such as
oxacillin, cefoxitin, and imipenem; (ii) vancomycin, and to a
lesser extent teicoplanin; (iii) antibiotics interfering with pep-
tidoglycan precursor formation, such as fosfomycin and baci-
tracin; and (iv) the glycyl-glycine endopeptidase lysostaphin,
which specifically cleaves the characteristic staphylococcal pep-
tidoglycan pentaglycine interpeptide (Table 3). Northern blots
showed that induction started immediately after addition of
the antibiotic. Induction of msrR reached its maximum after 30
min and decreased thereafter, presumably due to the antibiot-
ic’s effect on cell growth. The extent of the induction was found
to be concentration dependent and was higher when higher
oxacillin concentrations were added (data not shown).
Non-cell wall-active antibiotics such as trimethoprim, which
acts on folate synthesis, or ciprofloxacin, which inhibits DNA
gyrase, had no effect on msrR expression (Table 3). Similar
results were obtained by Northern blot analyses when protein
synthesis inhibitors such as tetracycline or erythromycin were
tested for their effects on msrR expression (data not shown).
Effects of msrR on sarA and agr. SarA is a global regulator
which controls the synthesis of virulence factors and stimulates
the transcription of the agr operon from the P2 and P3 pro-
moters (17; see review by Arvidson and Tegmark [2]). The sar
locus is composed of three overlapping transcripts, designated
sarA (0.56 kb), sarC (0.8 kb), and sarB (1.2 kb), originating
from the P1, P3, and P2 promoters, respectively, all encoding
the SarA protein (30). An impressive upregulation of the three
sarA transcripts was observed in msrR mutants, particularly
during the early exponential growth phase, up to an OD600 of
1 to 2, as shown in Fig. 4. The increase of sarA transcripts in the
mutant coincided precisely with the time of the otherwise high-
est msrR transcription in the wild type (Fig. 3A).
The SarA protein acts as an activator of the agr operon. We
therefore measured transcription of RNAIII, the effector mol-
ecule of the agr operon. RNAIII expression, which usually
begins in the stationary phase, started to increase in the msrR
mutant already during the exponential growth phase and ap-
peared also slightly stronger than in the wild type, as shown in
Fig. 4.
Effects of msrR on virulence factors. The global regulators
sarA and agr control a large number of cell wall-associated and
excreted proteins. We therefore analyzed the influence of
msrR inactivation on spa (coding for protein A) and hla (cod-
ing for alpha-toxin) transcription, respectively. The spa tran-
scription appeared to be reduced in the mutant compared to its
parent, especially in the stationary phase. In the very early
exponential phase, at an OD600 of 0.2, though, there appeared
to be more spa transcripts in the mutant than in the wild type.
The transcription of hla, in contrast, was enhanced and started
TABLE 3. Induction of msrR in strain J175 by antibiotics
Antibiotic MIC (g ml1) Fold inductiona
Oxacillin 0.125 3.2  0.50
Cefoxitin 3 3  0.59
Imipenem 0.032 3  0.97
Vancomycinb 1.5 4.5  1.30
Teicoplaninb 1.5 1.8  0.28
Bacitracin 48 5  1.48
Fosfomycin 1.5 2.5  1.27
Lysostaphin 0.008 4.7  1.84
Trimethoprim 0.75 0.96  0.09
Ciprofloxacin 0.25 0.98  0.09
a Fold increase in msrR transcription in strain J175 after 30 min of exposure to
antibiotics, determined by measuring the luciferase activity of msrRp-luc. The
values shown represent the means of three independent assays.
b Glycopeptides were added at 5 MICs due to scavenging of glycopeptides by
the cell wall, resulting in an inoculum effect.
FIG. 3. Expression profiles of msrA and msrR. (A) Expression of msrRp- luc during growth of S. aureus strain J175 was determined by
quantifying the luciferase activity (triangles). Bacterial growth was monitored by measuring the OD600 (squares). RLU, relative light units.
(B) Northern blot of msrA and msrR. Total RNA of strain MSSA1112 and its msrR mutant J156 was harvested at different growth stages indicated
as OD600 values above the lanes.
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earlier during growth in the mutant than in the wild type (Fig.
5).
Effects of MsrR on mecA transcription and autolytic activ-
ities. Since msrR inactivation reduced oxacillin resistance, the
transcription profile of mecA, the gene encoding the low-affin-
ity PBP2, which is responsible for methicillin resistance, was
analyzed in a wild-type strain and in the corresponding msrR
mutant. For this purpose, a plasmid containing a mecA pro-
moter-luciferase reporter gene fusion was introduced in parent
strain MSSA1112, yielding strain J198, and into the corre-
sponding msrR mutant J156, yielding strain J192. The mecA
transcription, though, was not affected in either strain by msrR
inactivation (data not shown). The effect of msrR inactivation
was further analyzed for the expression pattern of the endog-
enous PBPs in two genetically distinct methicillin-resistant S.
aureus strains. However, the PBP patterns were identical for
the methicillin-resistant strains and their corresponding msrR
mutants. There was also no change in the rate of spontaneous
autolysis in parent and mutant strains (data not shown).
DISCUSSION
MsrR shares high sequence identity and similarity with Psr,
the PBP5 synthesis repressor of E. faecalis and Enterococcus
hirae, and with LytR of B. subtilis. All belong to the LytR-
CpsA-Psr family of cell envelope-related transcriptional at-
tenuators, whose exact function has yet to be defined. Psr of
E. hirae, postulated to be a global regulator of cell wall syn-
thesis genes, was shown to alter the autolytic response by
reducing the cell wall’s content of rhamnose, a sugar occurring
in nonpeptidoglycan polysaccharides and teichoic acids, and to
repress PBP5 synthesis (31). Interestingly, the enterococcal
PBP5, which is associated with increased levels of ampicillin
resistance, has sequence similarity with the staphylococcal
methicillin resistance-determining PBP2, encoded by mecA.
The B. subtilis LytR was shown to act as an attenuator of the
expression of its own gene and of the divergently transcribed
lytABC operon, which codes for a lipoprotein, a modifier of an
N-acetylmuramoyl-L-alanine amidase, and the amidase itself
(28). It is worth noting that MsrR seemed to influence its own
expression (M. Bischoff and J. Rossi, unpublished results) and
that of the divergently transcribed msrA as well, with the latter
being strongly upregulated in msrR mutants.
The most important finding was that MsrR appeared to act
as an attenuator of sarA transcription. This is strongly sup-
ported by the remarkable sarA upregulation in msrR mutants
occurring during exponential phase, precisely the period of
otherwise peak msrR activity in the wild type. It is further
supported by the downregulation of sarA transcription in the
mutants to wild-type levels through msrAR trans-complemen-
tation (data not shown). The effect, though, is presumably not
mediated directly by MsrR, since no DNA-binding motifs were
found in the short predicted internal N-terminal fragment of
MsrR. Additional factors have therefore to be postulated as
intermediates leading from MsrR to sarA attenuation. The
same may be true for Psr, which was postulated to be a global
regulator of cell wall synthesis in E. hirae but seemed to act as
neither a transcriptional repressor nor an activator in Entero-
coccus faecium (38), suggesting that Psr, like MsrR, may be a
mediator for the regulatory effects.
Since SarA was known to be an activator of the agr operon
(18), the drastic changes in sarA transcription levels in the
msrR mutants were expected to influence agr expression. The
premature initiation and increased RNAIII transcription ob-
served in the msrR mutant may thus be explained by an in-
creased and earlier SarA production.
The altered activity profile of the global regulators sarA
and agr upon msrR inactivation was predicted to have conse-
quences for the synthesis of a variety of virulence factors (19).
We therefore investigated whether the msrR mutation influ-
enced the transcription of spa, known to be repressed by SarA
and RNAIII (13, 19), and of hla, which, on the other hand, is
upregulated by these two regulators (14). Consistently with the
previously demonstrated effects of msrR inactivation on sarA
FIG. 5. Northern blots of spa and hla transcripts in the wild-type
strain MSSA1112 and its msrR mutant J156, harvested during growth
at the OD600 values indicated and probed with hla or spa, respectively.
FIG. 4. Effect of msrR on the expression of the global regulators sarA and RNAIII. Shown are Northern blots of sarA and RNAIII transcripts
of the wild-type strain MSSA1112 and its derivatives J156 (msrR), J210 [J156 pAW17(msrAR)], and J209 (J156 pAW17) harvested during growth
at the OD600 values indicated.
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and RNAIII expression, we could observe a clear increase in
hla expression in the msrR mutant, which was again not only
stronger but appeared also earlier in growth. Expression of spa
seemed to be downregulated in the mutant, especially during
later growth stages, again consistent with the already-demon-
strated effect of the two global regulators. However, the reduc-
tion of spa transcripts in the mutant was less pronounced than
expected, pointing out the complex regulation of this cell wall-
associated protein. It has been shown that further regulatory
elements, such as SarS (SarH1) (15, 43), Rot (32), and ArlSR
(21), are involved in regulation of spa transcription.
Since msrR was expressed mainly during early exponential
growth in wild-type strains, effects of inactivation are expected
to manifest mainly during this growth phase and to a lesser ex-
tent over the remaining growth cycle. The early growth phase
is thought to mimic some of the conditions needed in the first
steps in the infection cycle of S. aureus, namely, the adhesion
to and colonization of the host. MsrR may therefore play a more
important role in vivo than in vitro, since except for reduced
resistance to certain antibiotics, the doubling time and growth
yield in vitro seemed not to be affected by msrR inactivation.
How the MsrR function correlates with glycopeptide and
methicillin resistance remains unclear. Many factors are known
to influence methicillin resistance levels. Resistance can be
lowered by preventing the production of PBP2 and/or by re-
ducing the expression of the endogenous PBPs. Peptidoglycan
precursor formation or changes in the peptidoglycan compo-
sition, as well as control of autolytic activities, can affect resis-
tance levels (reviewed in reference 7). The global regulators
sarA and agr were also shown to be involved in some way in
methicillin resistance (37). Glycopeptide resistance depends,
in most instances, on an abundant production of cell wall
precursors (27, 33) and genes involved in cell wall synthesis
(41). Since neither peptidoglycan composition and cross-link-
ing (K. Ehlert, personal communication) nor changes in the
PBP patterns or autolytic activities were apparent upon msrR
inactivation, other reasons for the reduced resistance have to
be sought. The effect of MsrR on resistance levels may be
attributed to its effect on the regulation of the global regula-
tors, which, besides virulence factors, may affect cell wall me-
tabolism. Alternatively, changes in cell wall constituents other
than peptidoglycan, such as teichoic acids, polysaccharides, or
capsule, are conceivable, since Streptococcus mutans LytR, sim-
ilarly to the B. subtilis LytR, was shown to be involved in
biofilm formation (47). An analogous function for MsrR may
be postulated. Predicated upon the upregulation of msrR by
inhibition of cell wall synthesis or degradation of the pepti-
doglycan, the primary function of MsrR may be in the response
to signals following cell wall damage or restructuring. It is
conceivable that MsrR acts as a sensor that relays an external
signal, possibly generated by cell wall metabolism during growth
or upon damage, to the cytoplasm. MsrR may be an intrinsic
low-level defense mechanism against cell wall damage that may
occur during infection and may affect the ability of S. aureus
to survive in different environments. Further experiments will
have to show if MsrR is of importance in adhesion to and
invasion and infection of the host, since its inactivation disturbs
the timing of virulence factor production.
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